PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Repurposing rheumatology drugs for COVID-19

2021-06-24
(Press-News.org) Rheumatologists are familiar with the everyday use of immunomodulatory drugs. These are designed to treat the inflammation caused by autoimmune diseases such as rheumatoid arthritis. A EULAR taskforce was set up to develop a set of new points to consider to give guidance and advice on the best way to use these medicines to treat COVID-19. The taskforce included rheumatologists, immunologists, haematologists, paediatricians, patients and other health professionals. They looked at the published evidence on the use of immunomodulatory therapies to treat severe COVID-19.

In total, there are two overarching principles and 14 points to consider. The principles stress that the picture of SARS-CoV-2 infection can be very different in different people. Infections range from asymptomatic or mild disease to severe or fatal. People with COVID-19 may need different treatment approaches, including antiviral medicines, oxygen therapy, anticoagulation and/or immunomodulatory treatment at different stages of the disease. The 14 points to consider are split into two categories: pathophysiology, and immunomodulatory therapy. Pathophysiology is about the disease itself. Immunomodulatory therapy is about how we might use existing medicines from the field of rheumatology to treat severe COVID-19. These give specific advice about which treatments to use at what stages of the disease. The picture is changing very quickly, which means there are some areas of uncertainty. EULAR intends to update the advice in response to increasing knowledge and evidence both about the disease, and the impact of COVID-19 vaccines.

These findings do not apply to people living with RMDs who are taking immunomodulatory treatments for their rheumatic disease. Separate recommendations are available for the management of people with RMDs in the context of the pandemic.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Ethane proxies for methane in oil and gas emissions

Ethane proxies for methane in oil and gas emissions
2021-06-24
Measuring ethane in the atmosphere shows that the amounts of methane going into the atmosphere from oil and gas wells and contributing to greenhouse warming is higher than suggested by the U.S. Environmental Protection Agency, according to an international team of scientists who spent three years flying over three areas of the U.S. during all four seasons. "Ethane is a gas that is related only to certain sources of methane," said Zachary R. Barkley, researcher in meteorology and atmospheric science, Penn State. "Methane, however, is produced by oil, ...

Points to consider for studies of work participation in people with inflammatory arthritis

2021-06-24
Understanding work participation is important, but the way in which this is defined and measured in clinical trials is not always the same, which has made it hard to compare data. EULAR set up a taskforce to draft points to consider when designing studies that use work participation as a measure. The taskforce included doctors, experts and patients from 11 countries. They used the published evidence to draw up a set of points to consider. Two overarching principles and nine points to consider were developed. The principles say that work participation is important for people with inflammatory arthritis, their ...

Mount Sinai study finds that rotator cuff injuries account for nearly half of shoulder injuries among collegiate baseball players, identifies other risks

2021-06-24
Paper Title: Analysis of Common Shoulder Injuries in Collegiate Baseball Players Journal: The Physician and Sportsmedicine (June 23, 2021, online edition) Authors: Alexis Chiang Colvin, MD, Professor, Department of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai; Daniel A. Charen, MD, Resident, Department of Orthopedic Surgery at the Icahn School of Medicine at Mount Sinai; and other coauthors. Bottom Line: Baseball players are highly susceptible to shoulder injuries due to significant microtrauma including repetitive overhead throwing. Mount Sinai researchers investigated men's National Collegiate ...

People with fibromyalgia are substituting CBD for opioids to manage pain

2021-06-24
Fibromyalgia is one of many chronic pain conditions that remains stubbornly difficult to treat. As the ravages of the opioid epidemic lead many to avoid these powerful painkillers, a significant number of people with fibromyalgia are finding an effective replacement in CBD-containing products, finds a new Michigan Medicine study. CBD, short for cannabidiol, is the second most common cannabinoid in the cannabis plant, and has been marketed for everything from mood stabilization to pain relief, without the intoxicating effects produced by the most common cannabinoid, THC. THC, which stands for ...

Membrane proteins of bacteria and humans show surprising similarities

Membrane proteins of bacteria and humans show surprising similarities
2021-06-24
The cells of simple organisms, such as bacteria, as well as human cells are surrounded by a membrane, which fulfills various tasks including protecting the cell from stress. In a joint project, teams from Johannes Gutenberg University Mainz (JGU) and Forschungszentrum Jülich, with participation of Heinrich Heine University Düsseldorf (HHU), have now discovered that a membrane protein found in bacteria has a similar structure and function as a group of proteins that are responsible for remodeling and rebuilding the cell membrane in humans. No connection between the two protein groups was known before. The team's research work has been published recently in the renowned journal Cell. PspA plays a key role in bacterial stress response The phage shock protein ...

Immunotherapy may be effective for subset of prostate cancer

2021-06-24
Boston - In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors. Prostate cancer, however, is considered a "cold" tumor, with few immune cells recognizing and infiltrating prostate malignancies. Accordingly, prostate cancer has been found to respond poorly to the class of immunotherapies known as immune checkpoint inhibitors. In previous work, a team led by medical oncologists at Beth Israel Deaconess Medical Center (BIDMC) identified a subset of prostate cancers that exhibited ...

Cosmic dawn occurred 250 to 350 million years after Big Bang

2021-06-24
Cosmic dawn, when stars formed for the first time, occurred 250 million to 350 million years after the beginning of the universe, according to a new study led by researchers at University College London (UCL) and the University of Cambridge. The study, published in the Monthly Notices of the Royal Astronomical Society, suggests that the NASA James Webb Space Telescope (JWST), scheduled to launch in November, will be sensitive enough to observe the birth of galaxies directly. The UK-led research team examined six of the most distant galaxies currently known, whose light has taken most of the universe's ...

Spreading of infections = need for collaboration between biology and physics

Spreading of infections = need for collaboration between biology and physics
2021-06-24
Researchers at the Niels Bohr Institute, University of Copenhagen, together with epidemiologist Lone Simonsen from Roskilde University form part of the panel advising the Danish government on how to tackle the different infection-spreading situations we have all seen unfold over the past year. Researchers have modelled the spread of infections under a variety of scenarios, and the Coronavirus has proven to not follow the older models of disease spreading. An increasingly varied picture of its behaviour and thus its impact on society has emerged. In several scientific articles, researchers ...

Versatile, fast and reliable SARS-CoV-2 antibody assay

Versatile, fast and reliable SARS-CoV-2 antibody assay
2021-06-24
During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies - either through infection or vaccination. Researchers at the Technical University of Munich (TUM) have now developed such a rapid antibody test. It provides the result in only eight minutes; the aim is to further reduce the process time to four minutes. There are currently more than 20 different test procedures available for determining whether a person has antibodies against the new Corona virus. The waiting times for the results range between ten minutes and two and a half hours. Matrix effects reduce the sensitivity of many of the methods. The more sensitive assays require numerous steps, ...

Are zebra mussels eating or helping toxic algae?

2021-06-24
While invasive zebra mussels consume small plant-like organisms called phytoplankton, Michigan State University researchers discovered during a long-term study that zebra mussels can actually increase Microcystis, a type of phytoplankton known as "blue-green algae" or cyanobacteria, that forms harmful floating blooms. "Microcystis literally means small cell, but numerous cells cluster together in colonies that can float to the surface to form scums," said Orlando Sarnelle, a professor emeritus with the Department of Fisheries and Wildlife within the College of Agriculture and Natural Resources. "It is one of the most common causes of nuisance algal blooms in nutrient-enriched waters, including Lake ...

LAST 30 PRESS RELEASES:

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

Fat may play an important role in brain metabolism

New study finds no lasting impact of pandemic pet ownership on human well-being

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Gut microbes could protect us from toxic ‘forever chemicals’

Novel modelling links sea ice loss to Antarctic ice shelf calving events

Scientists can tell how fast you're aging from a single brain scan

U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050

Public take the lead in discovery of new exploding star

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing

New book Terraglossia reclaims language, Country and culture

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

[Press-News.org] Repurposing rheumatology drugs for COVID-19